![Cecilia Driving](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Cecilia Driving
Directeur Financier/CFO chez
DICOT PHARMA AB
Fortune : 18 255 $ au 31/08/2026
Profil
Cecilia Driving is currently the Director at RISE Acreo AB and the Chief Financial Officer at Dicot Pharma AB starting in 2026.
Former roles include Chief Financial Officer, Deputy CEO & Executive VP at Biovica International AB from 2016 to 2022; Independent Director at Embracer Group AB from 2022 to 2025; Chief Financial Officer at W5 Solutions AB from 2025 to 2026; Chief Financial Officer at MedCap AB from 2008 to 2009; Chief Financial Officer at MedCap AB (Private Equity) from 2008 to 2009; Chairman at Adom AB; Director at Biovica Services AB; Independent Director at Ovzon AB; Chief Financial Officer at Abilia AB; and Group Chief Financial Officer at Mabtech AB. Education includes undergraduate and graduate degrees from the University of Stockholm.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
OVZON AB 0 % | 31/12/2025 | 4 500 ( 0 % ) | 18 255 $ | 31/08/2026 |
Postes actifs de Cecilia Driving
| Sociétés | Poste | Début |
|---|---|---|
| DICOT PHARMA AB | Directeur Financier/CFO | 01/07/2026 |
RISE Acreo AB
 RISE Acreo AB Miscellaneous Commercial ServicesCommercial Services Provides nanoelectronics, fiber optics and broadband technology solutions | Directeur/Membre du Conseil | - |
Anciens postes connus de Cecilia Driving
| Sociétés | Poste | Fin |
|---|---|---|
| W5 SOLUTIONS AB | Directeur Financier/CFO | 01/04/2026 |
| EMBRACER GROUP AB | Directeur/Membre du Conseil | 02/01/2025 |
| BIOVICA INTERNATIONAL AB | Directeur Financier/CFO | 31/12/2022 |
MedCap AB (Private Equity)
 MedCap AB (Private Equity) Investment ManagersFinance MedCap concentrates on investments in the Nordic region as well as in Europe, with a short- or medium-term outlook. The firm targets debt-free SMEs with substantial development potential and valued up to SEK 200 million, or having SEK 50 to 200 million in turnover. They target annual returns on each investment of at least 20 percent. MedCap typically acquires majority stakes in their portfolio companies. They may also take minority stakes, with a minimum of 20 percent. Their portfolio is generally composed of eight to ten firms. They are active investors. They provide experience and access to networks along with expansion capital when necessary. Their targeted investment horizon is five to seven years. MedCap also aims to consolidate the life science market in the Nordic region. To this end, they consider merging ownership to form more robust organizations, as well as collaborating on sales, and product development. They have invested in areas such as technical aids for persons with disabilities, healthcare technologies, systems for vacuum electrodes for ECG, micro-technology and miniaturized separation science, tissue engineering to develop functional substitutes for damaged tissues, and pharmacological solutions for treatment of nicotine addiction. | Directeur Financier/CFO | 31/12/2009 |
| MEDCAP AB | Directeur Financier/CFO | 01/12/2009 |
Formation de Cecilia Driving
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
62
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
RISE Acreo AB
RISE Acreo AB Miscellaneous Commercial ServicesCommercial Services Provides nanoelectronics, fiber optics and broadband technology solutions | Commercial Services |
MedCap AB
 MedCap AB Medical SpecialtiesHealth Technology Manufactures and sells radiological & ECG equipment, probiotics and nutritional supplements | Health Technology |
University of Stockholm
 University of Stockholm Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Abilia AB
 Abilia AB Packaged SoftwareTechnology Services Provides healthcare, welfare technology & devices for communication and social interaction | Technology Services |
MedCap AB (Private Equity)
MedCap AB (Private Equity) Investment ManagersFinance MedCap concentrates on investments in the Nordic region as well as in Europe, with a short- or medium-term outlook. The firm targets debt-free SMEs with substantial development potential and valued up to SEK 200 million, or having SEK 50 to 200 million in turnover. They target annual returns on each investment of at least 20 percent. MedCap typically acquires majority stakes in their portfolio companies. They may also take minority stakes, with a minimum of 20 percent. Their portfolio is generally composed of eight to ten firms. They are active investors. They provide experience and access to networks along with expansion capital when necessary. Their targeted investment horizon is five to seven years. MedCap also aims to consolidate the life science market in the Nordic region. To this end, they consider merging ownership to form more robust organizations, as well as collaborating on sales, and product development. They have invested in areas such as technical aids for persons with disabilities, healthcare technologies, systems for vacuum electrodes for ECG, micro-technology and miniaturized separation science, tissue engineering to develop functional substitutes for damaged tissues, and pharmacological solutions for treatment of nicotine addiction. | Finance |
Biovica International AB
 Biovica International AB BiotechnologyHealth Technology Operates as a biotechnology company which develops and commercializes blood-based biomarker assays | Health Technology |
Mabtech AB
 Mabtech AB BiotechnologyHealth Technology Develops and sells tests & kits for studying immune responses though online | Health Technology |
Embracer Group AB
 Embracer Group AB Packaged SoftwareTechnology Services Develops and publishes PC and console games for the global games market | Technology Services |
Dicot Pharma AB
 Dicot Pharma AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs to treat erectile failure | Health Technology |
Biovica Services AB | |
Adom AB | |
Ovzon AB
 Ovzon AB Major TelecommunicationsCommunications Provides mobile satellite communications services | Communications |
W5 Solutions AB
 W5 Solutions AB Electronics DistributorsDistribution Services Supplies high-tech systems and solutions | Distribution Services |
